CX-659S: a novel diaminouracil derivative that has antioxidative and acute anti-inflammatory activities

We investigated the antioxidative activities and the effects on acute inflammation in mice of a novel diaminouracil derivative, CX-659S (( S)-6-amino-5-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido)-3-methyl-1-phenyl-2,4(1 H,3 H)-pyrimidinedione). CX-659S showed potent scavenging activities ag...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmacology Vol. 438; no. 3; pp. 189 - 196
Main Authors Goto, Yuso, Watanabe, Nobuo, Kogawa, Noriaki, Tsuchiya, Masami, Takahashi, Osamu, Uchi, Hiroshi, Furue, Masutaka, Hayashi, Hideya
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 08.03.2002
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We investigated the antioxidative activities and the effects on acute inflammation in mice of a novel diaminouracil derivative, CX-659S (( S)-6-amino-5-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido)-3-methyl-1-phenyl-2,4(1 H,3 H)-pyrimidinedione). CX-659S showed potent scavenging activities against the hydroxyl radical and peroxynitrite and inhibited lipid peroxidation in rat brain homogenates in vitro. Topically applied CX-659S dose-dependently inhibited arachidonic acid- and 12- O-tetradecanoylphorbol 13-acetate (TPA)-induced ear edema in mice. Consistent with its antioxidative properties in vitro, CX-659S dramatically attenuated the accumulation of lipid peroxides in the mouse ear elicited by repeated application of TPA. Previously, we reported the effectiveness of CX-659S against contact hypersensitivity reactions in both mouse and guinea pig models. These present results further suggest the therapeutic potential of CX-659S for acute skin inflammation that may involve oxidative tissue damage.
ISSN:0014-2999
1879-0712
DOI:10.1016/S0014-2999(02)01340-7